PAA 2.78% 18.5¢ pharmaust limited

Ann: Commencement of Cohort 3 in Phase 1/2 MND Trial, page-38

  1. 11,532 Posts.
    lightbulb Created with Sketch. 5846
    Yes 2;53 onwards ,

    Plus earlier on he states we are monitoring many Oncology Companies...

    Plus when asked why now? he said Seagen had delivered new valuable data , compared to last year...

    Best PAA get the MND Biomarkers analysed ASAP.. Finish Cohort 4 on the increased dose,, meanwhile PAA Management get the Human Oncology and Human Covid Trials all written up, "awaiting supportive dose data" so the day the MND Data rolls in the Human Covid and Human Cancer Trials can start recruiting ...
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.005(2.78%)
Mkt cap ! $73.24M
Open High Low Value Volume
18.0¢ 18.5¢ 17.5¢ $68.67K 382.6K

Buyers (Bids)

No. Vol. Price($)
9 203260 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 57357 5
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
17.8¢ 18.0¢ 17.5¢ 253129
Last updated 15.56pm 27/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.